title: Obligate acceleromyography and pharmacologic reversal of all neuromuscular blocking agents: really, and where is the clinical outcome?
authors.forename: Paul M
authors.initials: PM
authors.lastname: Kempen
mesh_terms: D006801:Humans; D007702:Kinetocardiography; D009466:Neuromuscular Blocking Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D010243:Paralysis / Q000139:chemically induced / Q000188:drug therapy*; D011184:Postoperative Period
chemical_list: D009466:Neuromuscular Blocking Agents